President Trump Meets With Executives From The Pharmaceutical Industry In The Oval Office

WASHINGTON, DC - MAY 01: U.S. President Donald Trump (R) is joined by Gilead Sciences Chairman and CEO Daniel O'Day and Vice President Mike Pence to announce that the Food and Drug Administration issued an emergency approval for the antiviral drug remdesivir in the Oval Office at the White House May 01, 2020 in Washington, DC. A federal government trial found that patients with COVID-19 receiving Gilead Sciences' remdesivir recovered more quickly but the drug did not significantly reduce fatality rates. (Photo by Erin Schaff-Pool/Getty Images)
WASHINGTON, DC - MAY 01: U.S. President Donald Trump (R) is joined by Gilead Sciences Chairman and CEO Daniel O'Day and Vice President Mike Pence to announce that the Food and Drug Administration issued an emergency approval for the antiviral drug remdesivir in the Oval Office at the White House May 01, 2020 in Washington, DC. A federal government trial found that patients with COVID-19 receiving Gilead Sciences' remdesivir recovered more quickly but the drug did not significantly reduce fatality rates. (Photo by Erin Schaff-Pool/Getty Images)
President Trump Meets With Executives From The Pharmaceutical Industry In The Oval Office
ライセンスの購入
どんな用途に素材を使えますか?
¥38,500
JPY

詳細

制限:
商業目的またはプロモーション目的で使用する場合は、ゲッティ イメージズのオフィスへお問い合わせください。 報道、編集用途の全権利保有: UK、米国、アイルランド、カナダ(ケベックを除く)。 その他の国の日刊新聞での報道、編集用途の制限付きの権利については、電話にてお問い合わせください。
クレジット:
Pool / プール
報道写真番号:
1222297834
コレクション:
Getty Images News
作成日:
2020年05月01日(金)
アップロード日:
ライセンスタイプ:
リリース情報:
リリースされていません。 詳細情報
ソース:
Getty Images North America
オブジェクト名:
wh-6_2020050161225073.jpg
最大ファイルサイズ:
5304 x 3649 px (44.91 x 30.89 cm) - 300 dpi - 17 MB